Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AH Neuraminidase inhibitors
J05AH01 Zanamivir
D00902 Zanamivir (USP/INN) <US>
USP drug classification [BR:br08302]
Antivirals
Anti-influenza Agents
Zanamivir
D00902 Zanamivir (USP/INN)
Drug groups [BR:br08330]
Antiviral
DG03029 Anti-influenza virus agent
DG02842 Neuraminidase inhibitor
DG00664 Zanamivir
D00902 Zanamivir
Drug classes [BR:br08332]
Antiviral
DG03029 Anti-influenza virus agent
D00902 Zanamivir
Antimicrobials [BR:br08307]
Antivirals
Virus release inhibitor
Neuraminidase inhibitor
D00902 Zanamivir (USP/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D00902
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D00902
Drug groups [BR:br08330]
Antiviral
DG03029 Anti-influenza virus agent
DG02842 Neuraminidase inhibitor
DG00664 Zanamivir
Antimicrobials abbreviations [BR:br08327]
Antivirals
Virus release inhibitor
Neuraminidase inhibitor
DG00664 Zanamivir